The introduction of anaesthesia in 1846 opened up completely new fields of endeavour for the surgeons of that day and for their successors. No longer did surgery have to equate with a "smash and grab" approach where speed was of the essence. For the first time it was possible to operate in a considered and deliberate manner with the prospect of more elaborate and reparative procedures becoming a reality.
As surgery became safer with antisepsis, intraabdominal surgery became possible but operations inside the thorax remained a closed book. The ability to deal with the problems inherent in the creation of the necessary pneumothorax was still a long way off. Despite many attempts, regular intra-thoracic procedures had to await the recognition of the need for and eventually the advent of some form of assisted respiration or intermittent positive pressure ventilation. It was the introduction of muscle relaxants in 1942 which revolutionised how this could be accomplished.
Once the principles were understood, there were several exciting developments. In 1939 a patent ductus arteriosus was ligated, a repair of coarctation of the aorta was carried out in 1945, the Blalock Taussig shunt for palliative treatment of cyanotic congenital heart disease was introduced the same year and mitral valvotomy was successfully carried out before the end of the decade. The first ligation of a patient ductus was done in Northern Ireland by Barney Purce at the Royal Victoria Hospital in 1948, and the first mitral valvotomy was carried out by Tom Smiley also at the Royal in 1950.
All these procedures required minimal interruption of the circulation but they were nevertheless enormous advances. At that time monitoring, if used, was primitive, diathermy unavailable and pacemakers and the defibrillator were still to be invented.
This however was a beginning and as confidence increased, surgeons began to be even more adventurous. There were startling developments in anaesthesia with the introduction of less depressant and less explosive anaesthetic agents and with the gradual introduction of basic monitoring, anaesthesia was ready for the next step forward. Anything but the simplest procedures required the ability to stop the circulation for longer than 1-2 minutes. The advent of the use of moderate hypothermia to 30-32 degrees C allowed periods of circulatory arrest to be prolonged; 5-8 minutes became possible. Success depended on accurate diagnosis. This was not always possible and the risks were considerable.
There was an ever increasing demand for some form of cardiopulmonary bypass to allow time for more prolonged open heart surgery. The 1950s saw the successful culmination of many efforts and technical advances and in 1953 Gibbon and his co-workers in Philadelphia reported the first successful use of a heart lung machine to facilitate the closure of a secundum ASD in a teenage girl who has been a long term survivor. At that they reported the use of the same machine in several other cases but with no survivors. Even so, 1953 showed what was possible.
For an improvement in quality, there needed to be better diagnosis, anaesthesia, surgery, perfusion and intensive care. The rest of the 1950s saw many disasters and other methods such as cross circulation and profound hypothermia were tried but successful cardiopulmonary bypass also became more common. The defibrillator and the pacemaker arrived, monitoring improved steadily, anaesthetic agents appeared which were more suitable for the poor cardiovascular system and, with experience, better overall management was possible.
The first open heart case in the Congenital Heart Disease Congenital heart disease may change with social change. The falling birth-rate and abortion are great changes. But will genetic engineering bring change? Will intrauterine treatment have anything to offer? Or again will the allograft be thie answer to the most complex problems.
Perfusion
Perfusion apparatus has become smaller and smaller and more and more efficient. Will it become implantable with an arterial assist device or artificial heart in the circulation be the answer?
Anaesthesia
In thirty years anaesthesia will be non pharmaceutical, maybe electrical. Total pain relief without side effects will be available and operative episodes will pass without memory for unpleasantness.
Intensive Care
In intensive care the monitoring will demonstrate full data from non invasive techniques. The management loop will be closed so that the staff will be able to devote more time to the patients themselves. Myocardial preservation will eliminate the need for most inotropes and the better myocardium will decrease the stay needed in the intensive care.
Will these forecasts come true? Who will be around to see? At any rate I wish them good luck.
